These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24138422)

  • 1. Mathematical descriptors for the prediction of property, bioactivity, and toxicity of chemicals from their structure: a chemical-cum-biochemical approach.
    Basak SC
    Curr Comput Aided Drug Des; 2013 Dec; 9(4):449-62. PubMed ID: 24138422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: The Expanding Landscape of Graph Theoretic Molecular Descriptors: Development, Gradual Diversification of Descriptor Space, and Applications in QSAR/ QMSA and New Drug Discovery.
    Basak SC
    Curr Comput Aided Drug Des; 2017; 13(3):172-176. PubMed ID: 29517467
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using kernel alignment to select features of molecular descriptors in a QSAR study.
    Wong WW; Burkowski FJ
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(5):1373-84. PubMed ID: 21339534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR without borders.
    Muratov EN; Bajorath J; Sheridan RP; Tetko IV; Filimonov D; Poroikov V; Oprea TI; Baskin II; Varnek A; Roitberg A; Isayev O; Curtarolo S; Fourches D; Cohen Y; Aspuru-Guzik A; Winkler DA; Agrafiotis D; Cherkasov A; Tropsha A
    Chem Soc Rev; 2020 Jun; 49(11):3525-3564. PubMed ID: 32356548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoinformatics: Achievements and Challenges, a Personal View.
    Gasteiger J
    Molecules; 2016 Jan; 21(2):151. PubMed ID: 26828468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships.
    Ivanciuc O
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):153-63. PubMed ID: 23701000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches for choosing feature selection and learning algorithms in quantitative structure-activity relationships (QSAR).
    Khan PM; Roy K
    Expert Opin Drug Discov; 2018 Dec; 13(12):1075-1089. PubMed ID: 30372648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-linear modeling and chemical interpretation with aid of support vector machine and regression.
    Hasegawa K; Funatsu K
    Curr Comput Aided Drug Des; 2010 Mar; 6(1):24-36. PubMed ID: 20370693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of proper statistical practices in the use of chemodescriptors and biodescriptors in the twenty-first century.
    Basak SC
    Future Med Chem; 2019 Nov; 11(21):2755-2758. PubMed ID: 31686545
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and property landscape modeling is at the interface of chemoinformatics and medicinal chemistry.
    Medina-Franco JL; Navarrete-Vázquez G; Méndez-Lucio O
    Future Med Chem; 2015; 7(9):1197-211. PubMed ID: 26132526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational quantum chemistry and adaptive ligand modeling in mechanistic QSAR.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2010 Oct; 15(19-20):859-66. PubMed ID: 20709183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR Methods.
    Gini G
    Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Intrinsic Dimensionality of Chemical Spaces for Robust QSAR Model Development: A Comparison of Several Statistical Approaches.
    Majumdar S; Basak SC
    Curr Comput Aided Drug Des; 2016; 12(4):294-301. PubMed ID: 27600878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrotopological state atom (E-state) index in drug design, QSAR, property prediction and toxicity assessment.
    Roy K; Mitra I
    Curr Comput Aided Drug Des; 2012 Jun; 8(2):135-58. PubMed ID: 22497469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of geometry optimization methods on QSAR modelling: A case study for predicting human serum albumin binding affinity.
    Önlü S; Türker Saçan M
    SAR QSAR Environ Res; 2017 Jun; 28(6):491-509. PubMed ID: 28705017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-MoRSE descriptors explained.
    Devinyak O; Havrylyuk D; Lesyk R
    J Mol Graph Model; 2014 Nov; 54():194-203. PubMed ID: 25459771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on principles, theory and practices of 2D-QSAR.
    Roy K; Das RN
    Curr Drug Metab; 2014; 15(4):346-79. PubMed ID: 25204823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.